Search Results 41-50 of 14163 for anti-TNF drugs

  1. Postoperative Infections Clinical Trials - Mayo Clinic Research

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  2. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    ... drugs, surgical procedures or devices. Medical records research — uses ... Prior exposure to anti TNF agents, within 2 months, or 5 times the ...

  3. Behcet's disease - Diagnosis and treatment - Mayo Clinic

    Examples include infliximab (Remicade) and adalimumab (Humira). Side effects might include headache, skin rash and an increased risk of infections. Request an ...

  4. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

  5. Health care maintenance in patients with IBD - Mayo Clinic

    For example, patients who are receiving combination therapy with anti-TNF agents and an immunosuppressive drug have a blunted response to the pneumococcal ...

  6. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

    The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...

  7. Baricitinib (oral route) - Mayo Clinic

    ... TNF antagonist) that did not work well. ... Adalimumab; Adenovirus Vaccine Type 4, Live; Adenovirus ... drugs may be the best treatment for you. If both ...

  8. Certolizumab (subcutaneous route) - Mayo Clinic

    If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Abatacept; Adalimumab; Adenovirus ...

  9. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

    The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...

  10. Mayo Clinic Q and A: With psoriatic arthritis, the sooner therapy is started, the better

    NSAIDs — If your symptoms are mild, nonsteroidal anti ... Disease-modifying antirheumatic drugs (DMARDs) — These drugs ... TNF-alpha inhibitors block this substance ...